| Basics |
| Company: |
Intellia Therapeutics, Inc. |
| IPO Date: |
May 6, 2016 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.24B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.18 | 3.15%
|
| Avg Daily Range (30 D): |
$0.39 | 3.74%
|
| Avg Daily Range (90 D): |
$0.44 | 3.29%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.9M |
| Avg Daily Volume (30 D): |
2.92M |
| Avg Daily Volume (90 D): |
2.56M |
| Trade Size |
| Avg Trade Size (Sh.): |
69 |
| Avg Trade Size (Sh.) (30 D): |
93 |
| Avg Trade Size (Sh.) (90 D): |
88 |
| Institutional Trades |
| Total Inst.Trades: |
4,163 |
| Avg Inst. Trade: |
$3.02M |
| Avg Inst. Trade (30 D): |
$2.03M |
| Avg Inst. Trade (90 D): |
$2.26M |
| Avg Inst. Trade Volume: |
.07M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.95M |
| Avg Closing Trade (30 D): |
$3.16M |
| Avg Closing Trade (90 D): |
$3.72M |
| Avg Closing Volume: |
129.14K |
|
|
|
|
| News |
Feb 21, 2025 @ 10:43 PM
ROSEN, LEADING INVESTOR COUNSEL, Encourages Intell...
Source: N/A
|
Feb 19, 2025 @ 9:00 PM
NTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman, Llc
|
Feb 19, 2025 @ 12:04 AM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investo...
Source: Prnewswire
|
Feb 18, 2025 @ 2:27 PM
NTLA Investors Have Opportunity to Lead Intellia T...
Source: Prnewswire
|
Feb 16, 2025 @ 3:09 AM
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encou...
Source: N/A
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-5.45
|
$-1.34
|
$-1.52
|
|
Diluted EPS
|
$-5.45
|
$-1.34
|
$-1.52
|
|
Revenue
|
$ 43.09M
|
$ 9.11M
|
$ 6.96M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -522.28M
|
$ -135.71M
|
$ -146.98M
|
|
Operating Income / Loss
|
$ -537.71M
|
$ -144.77M
|
$ -139.04M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -46.88M
|
$ -10.35M
|
$ -41.13M
|
|
PE Ratio
|
|
|
|
|
